Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares S&P GSCI Commodity-Indexed Trust ETF (GSG) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

iShares S&P GSCI Commodity-Indexed Trust ETFTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares S&P GSCI Commodity-Indexed Trust ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? iShares S&P GSCI Commodity-Indexed Trust ETF trades at $36.18 (market cap $1.02B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 3.7× iShares S&P GSCI Commodity-Indexed Trust ETF's market cap, and iShares S&P GSCI Commodity-Indexed Trust ETF is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares S&P GSCI Commodity-Indexed Trust ETF for 41 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

GSGRLAY
Market Cap
$1.02B$3.82B
Volume
1,256,2214,332,079
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$37.15$20.75
52-Week Low
$22.45$6.03
Typical Hold Time
41 Days0 Days
Enterprise Value
—$2.93B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GSG
0% Buy100% Sell
Avg holding period · 41 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About iShares S&P GSCI Commodity-Indexed Trust ETF

GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.

Read more on GSG →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →